Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:06:15 EDT Fri 25 Sep 2026
Enter Symbol
or Name
USA
CA



Q:CYTK - CYTOKINETICS INC - https://www.cytokinetics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYTK - Q1.064.71·65.320.264.98-0.68-1.0129.48,38589765.68  65.945  64.9888.31  47.220409:47:54Sep 1715 min RT 2¢

Recent Trades - Last 10 of 897
Time ETExPriceChangeVolume
09:47:54Q64.946-0.7142
09:47:52Q64.87-0.796
09:47:52Q64.87-0.7988
09:47:52Q64.8005-0.859525
09:47:52Q64.8005-0.859548
09:47:52Q64.8005-0.85956
09:47:42Q65.05-0.61100
09:47:42Q65.00-0.66100
09:47:42Q65.05-0.61100
09:47:42Q64.98-0.6820

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-14 07:30U:CYTKNews ReleaseCytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
2026-09-02 16:00U:CYTKNews ReleaseCytokinetics to Participate in September Investor Conferences
2026-08-29 10:30U:CYTKNews ReleaseCytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
2026-08-28 05:45U:CYTKNews ReleaseCytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
2026-08-20 07:30U:CYTKNews ReleaseCytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
2026-08-18 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06 16:00U:CYTKNews ReleaseCytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-07-30 06:20U:CYTKNews ReleaseCytokinetics Announces MHRA Marketing Authorisation for MYQORZO(TM)▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales
2026-07-23 16:00U:CYTKNews ReleaseCytokinetics to Announce Second Quarter Results on August 6, 2026
2026-07-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-07 07:30U:CYTKNews ReleaseCytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026
2026-06-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-08 07:30U:CYTKNews ReleaseCytokinetics Announces Call for Proposals for Annual Corporate Giving Program
2026-06-01 07:30U:CYTKNews ReleaseCytokinetics Launches MYQORZO(TM) (aficamten) in European Union, with First Commercial Availability in Germany
2026-05-27 16:00U:CYTKNews ReleaseCytokinetics to Participate in June Investor Conferences
2026-05-20 16:00U:CYTKNews ReleaseCytokinetics to Hold Annual Meeting of Stockholders
2026-05-18 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2026-05-14 07:30U:CYTKNews ReleaseCytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)
2026-05-12 16:00U:CYTKNews ReleaseCytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference